Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Torrey Hills Capital

<< Previous

Bullboard Posts

Next >>

Post by rjc7on Aug 03, 2021 8:30am

219 Views

Post# 33641435

Torrey Hills Capital

Since we are a new client of theirs and they are under contract for one year, I suspect they will be watching our performance closely for a while. Assuming our quarter is as exciting as we expect it to be, they will be sure that Microbix is on the radar of all of their current clients. We should have some momentum going forward from the US market.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland